What is Bicara Therapeutics's income tax?

Bicara Therapeutics (BCAX) reported income tax of $46.75K in Q4 2024.

How has Bicara Therapeutics's income tax changed year-over-year?

Bicara Therapeutics's income tax increased by 3640.0% year-over-year, from $1.25K to $46.75K.

Discontinued — last reported Q4 '24

Reportable Segment$52K-27.8%

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Market cap$1.68B+81.4%

Enterprise value$1.36B+288%

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept bcax:IncomeTaxExpenseBenefitIncludingAdjustments.

The official record: Bicara Therapeutics’s 10-K, filed March 27, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Bicara Therapeutics's income tax?: Bicara Therapeutics (BCAX) reported income tax of $46.75K in Q4 2024.
How has Bicara Therapeutics's income tax changed year-over-year?: Bicara Therapeutics's income tax increased by 3640.0% year-over-year, from $1.25K to $46.75K.